TELL ME MORE

ABOUT THIS CLINICAL TRIAL for ATOPIC DERMATITIS

This is a Safety and Efficacy Study for children and adults age two or more years of age with Moderate to Severe Atopic Dermatitis (Eczema)

 

Atopic Dermatitis or Eczema

Clinical Trial for Atopic Dermatitis

Study Location(s): Evansville Indiana

Atopic Dermatitis (AD) is a type of Eczema and is most frequently associated with dry, itchy scaly skin.  The National Eczema Association estimates that over 30,000,000 people suffer with Eczema in the United States.  More than half (56%) of all Eczema patients have Atopic Dermatitis. This study includes an option to participate in an open-label, long-term extension.

There is no cost to participate.  Volunteers receive free investigational medicine and follow-up care.  No insurance needed.  Time and travel reimburrsement up to $560 may be available for participation in the first phase and up to $1400 including participation in the long-term extension study.

View More Studies

ConditionLocationStatusAge RangeSexMax Compensation 
ADHD
A Long-term active comparitor and dose optimization study to evaluate safety and efficacy of a non-stimulat medication
Bowling Green
Owensboro

Recruiting
6 - 17$1150Request Info
ALOPECIA AREATA
Safety and efficacy, placebo-controlled with open-label extension study in patients with severe alopecia areata
Owensboro
Recruiting
18 - 65$500Request Info
DIABETES (T2DM)
Active Comparator Study of a Dual Action versus Single Action Investigational Medicine on Glucose Control and Cardiovascular Events in Adults Age 40+ living with Type 2 Diabetes and CV Risk Factors
BowlingGreen
Owensboro

Recruiting
40 +$600/year (long-term study could last up to 5 years)Request Info
ECZEMA (Atopic Dermatitis)
Safety and efficacy, placebo-controlled study with open-label extension in patients with moderate to severe eczema
Evansville
Coming Soon
2+ (child through adult)$560 - $1400Request Info
IBD - CROHN'S DISEASE
A Safety and efficacy, placebo-controlled and active-controlled comparison study for patients with moderate to severe Crohn's Disease
Owensboro
Evansville

Recruiting
18 - 80$3200Request Info
IBD - ULCERATIVE COLITIS
A Safety and efficacy, placebo-controlled and active-controlled comparison study for patients with moderate to severe Ulcerative Colitis
Evansville
Recruiting
18 - 80$1100Request Info
IBS- CONSTIPATION
An efficacy and safety, placebo-controlled study for patients with constipation due to irritable bowel syndrome
BowlingGreen
Evansville

Recruiting
6 - 17$350Request Info
INFANT FORMULA
1. Fussy Baby Relief
2. Comparison Study
Evansville
Owensboro
EnrollingNewborns1. $150 + formula
2. $625 + formula
Request Info
INFANT VACCINE
Comparison Study between two meningococcal vaccines
EvansvilleRecruitingNewbornsVariable up to $400Request Info
INFANT VACCINE
Comparison Study between two pneumococcal vaccines
Bowling GreenRecruitingNewbornsVariable up to $400Request Info
LUPUS NEPHRITIS
A Safety, efficacy and tolerability study for patients with active Lupus Nephritis
EvansvilleEnrolling18 - 75$4625 ($125 per visit)Request Info
MIGRAINES in CHILDREN
A Double Blind, Placebo Controlled Study of an Investigational Medicine for Pediatric Migraines
BowlingGreen
Owensboro
Evansville

Recruiting
6 - 17$200/$350Request Info

Why are we asking for this information?

Baby’s due date/Birthday helps us ensure the diapers go to their intended recipients, expecting parents and newborns.  By registering for this giveaway you agree to let Qualmedica Reseasrch send information on infant formula and vaccine studies from time to time.  Click here for a complete listing of our privacy policy.

Pin It on Pinterest